Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

445 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients.
Malapelle U, Rossi G, Pisapia P, Barberis M, Buttitta F, Castiglione F, Cecere FL, Grimaldi AM, Iaccarino A, Marchetti A, Massi D, Medicina D, Mele F, Minari R, Orlando E, Pagni F, Palmieri G, Righi L, Russo A, Tommasi S, Vermi W, Troncone G. Malapelle U, et al. Among authors: massi d. Crit Rev Oncol Hematol. 2020 Dec;156:103118. doi: 10.1016/j.critrevonc.2020.103118. Epub 2020 Oct 3. Crit Rev Oncol Hematol. 2020. PMID: 33038627 Review.
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma.
Colombino M, Capone M, Lissia A, Cossu A, Rubino C, De Giorgi V, Massi D, Fonsatti E, Staibano S, Nappi O, Pagani E, Casula M, Manca A, Sini M, Franco R, Botti G, Caracò C, Mozzillo N, Ascierto PA, Palmieri G. Colombino M, et al. Among authors: massi d. J Clin Oncol. 2012 Jul 10;30(20):2522-9. doi: 10.1200/JCO.2011.41.2452. Epub 2012 May 21. J Clin Oncol. 2012. PMID: 22614978
BRAF and KIT somatic mutations are present in amelanotic melanoma.
Massi D, Pinzani P, Simi L, Salvianti F, De Giorgi V, Pizzichetta MA, Mirri F, Steffan A, Orlando C, Santucci M, Canzonieri V. Massi D, et al. Melanoma Res. 2013 Oct;23(5):414-9. doi: 10.1097/CMR.0b013e32836477d4. Melanoma Res. 2013. PMID: 23938765
Discrepant alterations in main candidate genes among multiple primary melanomas.
Colombino M, Sini M, Lissia A, De Giorgi V, Stanganelli I, Ayala F, Massi D, Rubino C, Manca A, Paliogiannis P, Rossari S, Magi S, Mazzoni L, Botti G, Capone M, Palla M, Ascierto PA, Cossu A, Palmieri G; Italian Melanoma Intergroup (IMI). Colombino M, et al. Among authors: massi d. J Transl Med. 2014 May 8;12:117. doi: 10.1186/1479-5876-12-117. J Transl Med. 2014. PMID: 24885594 Free PMC article.
Nras in melanoma: targeting the undruggable target.
Mandalà M, Merelli B, Massi D. Mandalà M, et al. Among authors: massi d. Crit Rev Oncol Hematol. 2014 Nov;92(2):107-22. doi: 10.1016/j.critrevonc.2014.05.005. Epub 2014 Jun 12. Crit Rev Oncol Hematol. 2014. PMID: 24985059 Review.
Epidemiological features and prognostic parameters of multiple primary melanomas in CDKN2A-mutations patients.
De Giorgi V, Savarese I, D'Errico A, Gori A, Papi F, Colombino M, Sini MC, Grazzini M, Stanganelli I, Rossari S, Covarelli P, Massi D, Palmieri G. De Giorgi V, et al. Among authors: d errico a, massi d. Pigment Cell Melanoma Res. 2015 Nov;28(6):747-51. doi: 10.1111/pcmr.12403. Pigment Cell Melanoma Res. 2015. PMID: 26223839 No abstract available.
445 results